[1] Zhang C, Tian Z. NK cell subsets in autoimmune diseases[J].J Autoimmun, 2017, 83:22 [2] Post M, Cuapio A, Osl M, et al. The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development[J].Front Immunol, 2017,8:535 [3] Holmes M L, Huntington N D, Thong R P, et al. Peripheral natural killer cell maturation depends on the transcription factor Aiolos[J].EMBO J, 2014, 33(22): 2721 [4] Bollino D, Webb T J. Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy[J].Transl Res, 2017,187:32 [5] Sun J C, Lanier L L. NK cell development, homeostasis and function: parallels with CD8(+) T cells [J].Nat Rev Immunol, 2011,11(10):645 [6] Lopez-Soto A, Gonzalez S, Smyth M J, et al. Control of Metastasis by NK Cells [J].Cancer Cell,2017, 32(2):135 [7] Narni-Mancinelli E, Chaix J, Fenis A, et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor[J].Proc Natl Acad Sci U S A, 2011,108(45):18324 [8] Deng Y, Kerdiles Y, Chu J, et al. Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function[J].Immunity,2015, 42(3):457 [9] Male V, Brady H J. Transcriptional control of NK cell differentiation and function[J]. Curr Top Microbiol Immunol,2014,381:173 [10] Moretta L, Montaldo E, Vacca P, et al. Human natural killer cells: origin, receptors, function, and clinical applications[J].Int Arch Allergy Immunol, 2014,164(4):253 [11] Paolini R, Bernardini G, Molfetta R, et al. NK cells and interferons[J]. Cytokine Growth Factor Rev,2015,26(2):113 [12] Levy E M, Roberti M P, Mordoh J. Natural killer cells in human cancer: from biological functions to clinical applications[J].J Biomed Biotechnol,2011, 2011:676198 [13] Hsu H T, Mace E M, Carisey A F, et al. NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing[J].J Cell Biol,2016, 215(6):875 [14] Leavy O. Maturation and function of NK cells[J].Nat Rev Immunol, 2012,12(3): 150 [15] Guan C, Ye C, Yang X, et al. A review of current large-scale mouse knockout efforts[J].Genesis,2010,48(2):73
[1]王 玲 综 述,徐燕颖 审 校.自然杀伤细胞表面NKp30受体的研究进展[J].天津医科大学学报,2019,25(05):544.
作者简介 于明航(1991-),男,硕士在读,研究方向:肿瘤免疫;通信作者:王玺,E-mail:wangxi@tmu.edu.cn。